Informing Clinical Trial Participants About Study Results
- 17 July 2002
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 288 (3), 363-365
- https://doi.org/10.1001/jama.288.3.363
Abstract
Of the 1.3 million individuals diagnosed with cancer each year in the United States, a substantial minority participate in clinical trials. When patients agrKeywords
This publication has 17 references indexed in Scilit:
- How Sociodemographics, Presence of Oncology Specialists, and Hospital Cancer Programs Affect Accrual to Cancer Treatment TrialsJournal of Clinical Oncology, 2002
- Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast CancerNew England Journal of Medicine, 2000
- Randomized Trial of High-Dose Chemotherapy and Blood Cell Autografts for High-Risk Primary Breast CarcinomaJNCI Journal of the National Cancer Institute, 2000
- Protecting communities in research: current guidelines and limits of extrapolationNature Genetics, 1999
- Participatory research maximises community and lay involvementBMJ, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Participatory Research with Native Community of Kahnawake Creates Innovative Code of Research EthicsCanadian Journal of Public Health, 1998
- The rights of patients in researchBMJ, 1995
- Doctor-patient communication: A review of the literatureSocial Science & Medicine, 1995
- Participation in a clinical trial: The patients' point of viewControlled Clinical Trials, 1985